Top 50 Personalized Medicine

The startup utilizes artificial intelligence and biochip technology to simulate patient drug reactions, enabling precise predictions of individual responses to medications. This approach provides tailored medical solutions, enhancing patient outcomes through data-driven insights into optimal drug therapies.

NextBio utilizes organoid technology and molecular diagnostics to create personalized medicine solutions for researchers and consumers. This approach enables precise drug testing and tailored treatment plans, addressing the limitations of traditional one-size-fits-all medical therapies.

This health tech company provides personalized polypharmacy treatments for cardiometabolic diseases. Their platform optimizes drug combinations to enhance efficacy, minimize side effects, and reduce pharmaceutical waste, enabling healthcare professionals to deliver more effective and sustainable patient care.

The startup operates an online pharmacy that provides personalized medication and 24/7 medical consultations, ensuring patients receive tailored healthcare solutions. By delivering prescriptions directly to users' doorsteps, the service addresses the challenge of accessibility to timely medical care and medication management.

The startup develops personalized medicine solutions that leverage novel biological discoveries to enhance treatment options for patients. By enabling clinical, pharmaceutical, and diagnostic companies to integrate tailored diagnostics and prognostics, the company addresses the need for more effective and individualized healthcare interventions.

The startup develops personalized pharmaceutical technology that tailors medication regimens based on individual patient profiles, enhancing therapeutic efficacy and minimizing adverse effects. By utilizing advanced data analytics and pharmacogenomics, the company aims to improve patient outcomes and overall quality of life.

The startup has developed a therapeutic platform that utilizes artificial intelligence and big data to create targeted molecules for treating rare cancers. This approach enables physicians to access more effective drugs tailored to individual patient needs, improving treatment outcomes.

The startup operates a personalized healthcare platform that provides individualized medical treatments, including hormone replacement therapy and Chinese herbal medicine, specifically for menopausal women. By offering tailored prescriptions, supplements, counseling, and dietary advice, the platform addresses the unique health needs of this demographic, promoting both physical and mental well-being.

The startup develops a machine learning algorithm for precision medicine in oncology, focusing on the identification and quantification of cancer-causing mutations and their impact on treatment options. By analyzing RNA data and clinical characteristics, the platform enables personalized treatment recommendations and reduces unnecessary drug prescriptions.

The startup operates a drug discovery platform that employs artificial intelligence to analyze tumor DNA patterns, predicting patient responses to cancer therapies. This enables physicians to make data-driven decisions for personalized treatment in pan-cancer precision medicine.

This company develops a platform that integrates generative AI with real-world evidence to advance precision medicine. The technology links multi-omics biomarkers to drug response and adverse-event risk, providing pharmacogenomic recommendations. This capability accelerates drug development timelines and supports clinicians in delivering optimized treatment protocols.

The startup develops molecular diagnostic tests that provide clinically actionable insights for immunotherapy decisions in oncology, specifically targeting patients with metastatic solid tumors. By offering personalized medicine solutions, the company equips drug developers, clinical oncologists, and healthcare payers with essential data to optimize immunotherapy treatment options.

The startup operates a personalized medicine platform that utilizes vascular biology, artificial intelligence, and novel blood biomarkers for the early detection and monitoring of neurodegenerative, autoimmune, cardiovascular, and neuropsychiatric diseases. By enabling precise diagnostics, the platform enhances patient care and treatment outcomes through timely interventions.

Cygenex provides genetic and pharmacogenomic testing integrated with data analytics to deliver personalized medication recommendations based on individual genetic profiles. This service enhances medication efficacy and reduces the risk of adverse drug reactions in patients.

PGxCare provides an AI-powered pharmacogenetics platform that analyzes genetic data to deliver personalized drug therapy recommendations. This technology ensures safe and effective treatment by identifying optimal medications and potential drug interactions based on individual genetic profiles.

Accelerated Pharma is developing targeted therapies for cancer using advanced biomarker identification and personalized medicine approaches. The company addresses the challenge of ineffective treatments by tailoring therapies to individual patient profiles, improving treatment efficacy and patient outcomes.

CONSUSIS provides AI-driven tools for precision medicine, enabling healthcare professionals to deliver personalized treatment plans based on advanced diagnostics and analytics. By streamlining access to high-quality medical technologies, the platform reduces unnecessary costs while enhancing patient-centric care.

Metsystem is developing a personalized medicine platform that utilizes a decision support tool to predict cancer metastasis and guide oncologists in selecting the most effective therapies for patients with solid tumors. This approach addresses tumor heterogeneity, enabling earlier intervention and improved patient outcomes through targeted drug screening and risk assessment.

Chi Biomedicine utilizes next-generation sequencing (NGS) technology to provide genetic testing and analysis for personalized healthcare and medication management. The company addresses the need for precise medical guidance by offering insights into genetic predispositions, enabling proactive health management and tailored treatment plans.

Genome Wisdom provides a gene-based precision medical technology service that utilizes genetic data analysis to deliver personalized health insights. This approach enables healthcare providers to tailor treatment plans based on individual genetic profiles, improving patient outcomes and reducing ineffective therapies.

TopGene specializes in precision medicine through advanced gene detection technologies, focusing on identifying tumor-specific genetic markers for personalized treatment plans. This approach enhances diagnostic accuracy and treatment efficacy for cancer patients, addressing the need for tailored medical solutions in oncology.

This pharmacotherapy company offers pharmacogenetic testing to personalize medication plans based on a patient's genetic profile. By analyzing individual gene responses to drugs, they help healthcare providers optimize medication efficacy and safety, ensuring patients receive the most appropriate drug and dosage.

The startup has developed a precision medicine platform that utilizes molecular signature tests to match autoimmune disease patients with the most effective drug based on their unique disease biology. This approach eliminates reliance on symptoms or medical bias, ensuring optimal treatment is prescribed from the outset.

The startup develops an AI-driven cancer treatment solution that utilizes multi-modal datasets, including whole slide images, genomic data, and electronic health records from the developing world. This approach enhances precision medicine by optimizing patient outcomes and improving clinical efficiency for pharmaceutical and biotech partners.

The startup develops automated microfluidic 3D cellular assays that enable the testing of up to 800 conditions on 1,000 microtumors simultaneously, significantly reducing the required patient sample size. This technology accelerates drug discovery and enhances the predictability of patient-specific responses to cancer therapies, addressing the inefficiencies in traditional biopsy testing methods.

The startup develops a precision medicine support tool that utilizes patient and tumor-specific data to model treatment responses for leukemia. By providing real-time predictions of tumor behavior and patient recovery, the platform enables healthcare organizations to deliver personalized treatment plans that enhance patient outcomes.

Known Medicine develops an organoid platform that utilizes machine learning-based sensitivity assays and omics data to analyze cancer cells from patient fluid samples. This technology enables oncologists to identify predictive biomarkers for drug response, facilitating personalized treatment strategies for cancer patients.

Stack Diagnostics utilizes genomics and artificial intelligence to enhance diagnostic accuracy and treatment personalization in healthcare. The company addresses the challenge of inefficient and generalized medical diagnoses by providing tailored genomic insights for improved patient outcomes.

Genetic Foresight utilizes genetic testing to analyze individual responses to medications, ensuring personalized prescriptions that enhance efficacy and minimize adverse effects. This approach addresses the challenge of adverse drug reactions by tailoring treatment plans based on a patient's unique genetic profile.

Valius Sciences develops personalized cancer maps by analyzing DNA, RNA, and protein profiles to uncover specific tumor weaknesses. This comprehensive molecular insight guides the identification of the most effective targeted therapies for individual patients. The company translates these complex omics data into actionable treatment strategies for clinicians.

Gedroic Medical Institute uses precision medicine to treat chronic illnesses through a holistic approach. They offer personalized treatment plans that address the root causes of disease, rather than just managing symptoms. This allows patients to achieve long-term health and wellness.

Genomate provides computational intelligence software to analyze a cancer patient's unique molecular profile and tumor alterations. This analysis predicts responses to multiple targeted therapies, enabling oncologists to select optimal, personalized treatment plans. The platform delivers data-backed reports to improve treatment outcomes and efficiency in precision oncology.

The startup develops a microfluidic device that enables personalized drug selection for cancer patients by analyzing the effectiveness of standard treatments before therapy begins. This technology provides oncologists and pharmaceutical clients with critical insights, improving treatment outcomes and reducing trial-and-error in medication selection.

Wisdom Medicine provides personalized virtual healthcare for women, focusing on gut and hormone health through dedicated teams of licensed naturopathic doctors and functional nutritionists. By offering extended appointment times and transparent pricing, the service addresses common women's health issues such as menstrual discomfort and hormonal imbalances with a commitment to patient satisfaction.

OncXerna Therapeutics utilizes an RNA-based biomarker platform to deliver precision medicine for cancer treatment. This technology enables the identification of specific tumor characteristics, allowing for tailored therapeutic strategies that improve patient outcomes.

This startup analyzes genetic and lifestyle data to deliver personalized healthcare recommendations. By providing actionable insights based on an individual's unique health profile, they aim to improve health outcomes through tailored interventions.

The startup utilizes computational biomedicine techniques to analyze genomic and clinical data for precision oncology, enabling personalized treatment plans for cancer patients. By identifying specific biomarkers and genetic mutations, the company enhances treatment efficacy and reduces adverse effects associated with traditional therapies.

Single Helix Genomics has developed an automated, portable device that delivers therapeutics on demand, utilizing advanced genomic technologies for precise treatment applications. This device addresses the need for immediate and personalized therapeutic solutions in various medical settings, enhancing patient care and treatment efficiency.

The startup provides genomic profiling services that enable individuals to assess their genetic predisposition to diseases, particularly cancer, through advanced DNA sequencing and analysis. By identifying genetic risks early, the company facilitates timely interventions and personalized treatment strategies based on individual genetic profiles.

GenomeKey utilizes advanced genomic sequencing technology to analyze genetic data for personalized medicine applications. The company provides insights that enhance treatment efficacy and reduce adverse drug reactions, improving patient outcomes in healthcare.

The startup provides a platform that utilizes precision data analytics to enhance personalized treatment plans in precision medicine. By integrating genomic and clinical data, it enables healthcare providers to make more informed decisions, improving patient outcomes and reducing trial-and-error in treatment selection.

The startup specializes in processing and analyzing autologous adipose-derived stem cells from patients' fat, providing services that include sterility testing, endotoxin assessment, and cell identity verification. This enables physicians to develop clinical protocols for treating osteoarthritis in compliance with FDA regulations.

The startup utilizes machine learning algorithms to analyze complex medical data, enabling the customization of treatment plans based on individual patient profiles. This approach addresses the challenge of one-size-fits-all treatment methods, improving patient outcomes through tailored healthcare solutions.

This startup provides bioinformatics solutions for drug discovery and development, focusing on personalized and precision therapies. Their services include CRISPR/siRNA selection, customized reference genomes, target discovery, and mechanism of action identification, helping healthcare firms accelerate drug development for cancers and rare diseases.

UGenome provides bioinformatics software tools, MAXX and ProPEx, for somatic variant detection and pharmacogenomic analysis to enhance medication response. The platform delivers clinically actionable insights that improve treatment options for patients by personalizing genomic medicine.

The startup has developed a personalized medication monitoring platform that utilizes DNA sequencing to analyze patients' genetic profiles. This technology identifies optimal drug prescriptions, leading to reduced healthcare costs and improved patient outcomes.

Phenomics Health is a bioinformatics platform that integrates genomic and phenotypic data to create personalized treatment plans for patients. The platform enhances therapeutic outcomes by providing insights tailored to individual biological profiles, addressing the inefficacy of standard treatment approaches.

BioAro utilizes genetic sequencing and analysis to develop personalized medicine solutions tailored to individual patient profiles. This approach provides targeted therapies that enhance treatment efficacy and minimize adverse effects, addressing the limitations of standard treatment protocols.

This biotechnology company utilizes pharmacogenomics and precise detection methods to create personalized prescription medications tailored to individual genetic profiles. By offering affordable genetic products, the company enables patients to enhance their health outcomes through targeted therapies.

The startup utilizes polymathic AI to deliver precision medicine by analyzing complex biological data and patient information. This approach enhances treatment personalization, improving patient outcomes in healthcare by tailoring therapies to individual genetic profiles.